Recruiting
Phase 1

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Sponsor:

Schrödinger, Inc.

Code:

NCT05961839

Conditions

Acute Myeloid Leukemia

High-Risk and Very High-Risk Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SGR-2921

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information